Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study

By Zivadinov Robert   Ramanathan Murali   Ambrus Julian   Hussein Sara   Ramasamy Deepa P   Dwyer Michael G   Bergsland Niels   Minagar Alireza   Weinstock-Guttman Bianca  

Neurological Research, Vol. 34, Iss. 8, 2012-10 ,pp. : 761-769

Maney Publishing

Access to resources Recommend Favorite

T 1 hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment

By Pozzilli C.  

Brain, Vol. 124, Iss. 7, 2001-07 ,pp. : 1396-1402

Oxford University Press

Access to resources Recommend Favorite

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis

By Molyneux P.D.   Kappos L.   Polman C.   Pozzilli C.   Barkhof F.   Filippi M.   Yousry T.   Hahn D.   Wagner K.   Ghazi M.   Beckmann K.   Dahlke F.   Losseff N.   Barker G.J.   Thompson A.J.   Miller D.H.  

Brain, Vol. 123, Iss. 11, 2000-11 ,pp. : 2256-2263

Oxford University Press

Access to resources Recommend Favorite

Efficacy and safety of interferon beta-1b sc in older RRMS patients—a posthoc analysis of the BEYOND study

By Lampl Christian   Nagl Stefan   Arnason Barry   Comi Giancarlo   O′Connor Paul   Cook Stuart   Jeffery Douglas   Kappos Ludwig   Filippi Massimo   Beckmann Karola   Bogumil Timon   Pohl Christoph   Sandbrink Rupert   Hartung Hans  

Journal of Neurology, Vol. 260, Iss. 7, 2013-07 ,pp. : 1838-1845

Springer Publishing Company

Access to resources Recommend Favorite

Plasma ubiquitin-proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b

By Minagar Alireza   Ma Wanlong   Zhang Xi   Wang Xiuqiang   Zhang Ke   Alexander J Steven   Gonzalez-Toledo Eduardo   Albitar Maher  

Neurological Research, Vol. 34, Iss. 6, 2012-07 ,pp. : 611-618

Maney Publishing

Access to resources Recommend Favorite